Navigation Links
Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO
Date:1/6/2009

treatment of advanced kidney cancer and liver cancer. Additionally, Nexavar is being investigated in several ongoing trials in non-small cell lung cancer, melanoma, breast cancer, and other cancers. For more information about Onyx, visit the company's website at http://www.onyx-pharm.com.

About S*BIO Pte Ltd

S*BIO is a privately-held biotechnology company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer. The company's lead programs focus on histone deacetylases (HDAC) and kinases. S*BIO has an established R&D infrastructure that is complemented by a clinical development team. In addition, S*BIO has links with a network of medical oncologists in Asia Pacific. More information about S*BIO can be found at www.sbio.com.

Forward-Looking Statements

This news release contains "forward-looking statements" within the meaning of the federal securities laws. These forward-looking statements include, without limitation, statements regarding potential clinical applications for SB1518 and SB1578, the potential for their development and commercialization, the clinical development, regulatory processes, and commercialization efforts related to Nexavar and Onyx's expectation that it will be profitable on a non-GAAP basis for the 2008 fiscal year. These statements are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated. Reference should be made to Onyx's Annual Report on Form 10-K for the year ended December 31, 2007, filed with the Securities and Exchange Commission under the heading "Risk Factors" and Onyx's Quarterly Reports on Form 10-Q for a more detailed description of such factors. Readers are cautioned not to place undue reliance on forward-looking statements
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Akrimax Pharmaceuticals Announces Manufacturing Partnership
2. Prism Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference
3. Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R) for Life-Threatening Ventricular Fibrillation and Ventricular Tachycardia
4. AUDIO from Medialink and Solvay Pharmaceuticals: New Initiative Urges Women to Address Mens Health this New Year
5. Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
6. Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals
7. Alexion Pharmaceuticals and PDL BioPharma Resolve Patent Dispute
8. Watson Pharmaceuticals Receives FDA Approval for Mint Coated Nicotine Gum
9. Watson Pharmaceuticals Receives FDA Final Approval for Generic Mircette(R)
10. Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc.
11. Cognition Pharmaceuticals Announces Positive Memory Results for Phase II Trial of C105 in Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... (PRWEB) December 26, 2014 India Network ... insurance in the USA, announced today a new version ... members in choosing the right plan for their visiting ... complexity out of the selection process when choosing an ... age group with only a few clicks. Many elderly ...
(Date:12/26/2014)... December 26, 2014 Parker & ... the best in heating, cooling and plumbing contractor ... hour emergency services in 2014 with regard to ... that Arizona is known for its incredibly hot ... understands the intricacies and details of a wide ...
(Date:12/25/2014)... The click strand woven bamboo flooring ... the business announces a click strand woven bamboo ... 2015. , Click strand woven bamboo flooring replicates ... well-known brand in the bamboo industry. It promises ... bamboo flooring supplier. , “We are happy to ...
(Date:12/25/2014)... 25, 2014 Product liability lawsuits filed ... recall ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in ... Order issued in the U.S. District Court, Northern District ... an open conference on January 7, 2015, at the ... in West Palm Beach, Florida. The Conference is scheduled ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online ... its collection of discounted prom dresses, most of which ... spokesman of the company, the promotion is valid until ... to expand the UK market. , The prom dresses ... lengths, and styles: A-line strapless, empire strapless chiffon, one ...
Breaking Medicine News(10 mins):Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 2Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 3Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2
... than can strike younger adults , , WEDNESDAY, March 11 ... test for quick diagnosis of a rare but potentially ... sudden death in young people. , The disease is ... flaw causes the muscle cells of one of the ...
... Stigmatize a Health FoodSAN FRANCISCO, March 11 Today ... verdict in a 2006 case which established that the ... occurring, and too insignificant to require warning labels. A ... Deputy Attorney General Sue Fiering argued that the labels ...
... HOUSTON, March 11 Salmonella bacteria research ... key elements of the bacteria,s disease-causing potential ... fight food-borne infections on Earth.(Logo: ... of food poisoning and related illnesses. According ...
... of Your Diabetes (TCOYD) conference and health fair will ... Center, bringing national and local medical experts in diabetes ... at risk for diabetes, and their loved ones for ... will discuss practical advice and developments in the treatment ...
... of the flu shot across the nation, has announced the availability ... ... 11, 2009-- Nationwide Medical/Surgical, a leading provider of the flu shot ... flu vaccine ., , ,The influenza virus, more commonly known as ...
... Grammy Award-winning singer advocates for research into disease ... Award-winning artist LeAnn Rimes shared her personal story ... psoriasis, and she encouraged lawmakers to support much-needed ... autoimmune disease."I was first diagnosed with psoriasis at ...
Cached Medicine News:Health News:New Test Seems to Spot Deadly Heart Condition 2Health News:New Test Seems to Spot Deadly Heart Condition 3Health News:Consumers Win Major Victory Over Seafood Scaremongers 2Health News:Space Research May Help Explain Salmonella Illness 2Health News:Space Research May Help Explain Salmonella Illness 3Health News:Taking Control of Your Diabetes Conference Returns to Hawaii to Bring Answers, Advocacy and Hope for People with Diabetes 2Health News:Nationwide Medical/Surgical Announces Preservative Free Flu Vaccine Available 2Health News:LeAnn Rimes Shares Her Personal Struggle With Psoriasis in Nation's Capital 2Health News:LeAnn Rimes Shares Her Personal Struggle With Psoriasis in Nation's Capital 3Health News:LeAnn Rimes Shares Her Personal Struggle With Psoriasis in Nation's Capital 4
(Date:12/24/2014)... International Trade Commission (ITC) issued its final decision in the ... notice issued on December 23, the ITC ruled in favor ... was invalid. BMC President, James Xu ... with the ITC,s decision in this case. This victory for ... very beginning on the key patents in the case. ResMed ...
(Date:12/24/2014)... Dec. 23, 2014 PuraMed BioScience®, Inc., (OTC ... (OTC) medicinal and healthcare products, announced it received the ... a hemp-based, advanced headache relief product, for planned distribution ... Colorado , Washington State ... With the MigraPure H Advanced headache relief gel formulation ...
(Date:12/24/2014)... , Dec. 23, 2014   Synageva ... a biopharmaceutical company developing therapeutic products for rare ... Agency (EMA) of the Marketing Authorization Application (MAA) ... recently granted the company,s request for accelerated assessment, ... regulatory review time.   The MAA, ...
Breaking Medicine Technology:ITC Final Decision Goes Against ResMed (RMD) Monumental Win for 3B/BMC 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3
... May 10, 2011 Cardica, Inc. (Nasdaq: CRDC ... and nine months ended March 31, 2011. Cardica,s management will ... to discuss the financial results and provide an update on ... diligently to bring our first anticipated commercial microcutter device, the ...
... 10, 2011 Cobalis Corp. (CLSC.PK) announced today they ... Allergy Defense Formula , on major national cable and ... featuring leading US allergist Dr. Paul H. Ratner, MD, ... allergies, giving seasonal and year-round sufferers the first truly ...
Cached Medicine Technology:Cardica Announces Fiscal 2011 Third Quarter Financial Results 2Cardica Announces Fiscal 2011 Third Quarter Financial Results 3Cardica Announces Fiscal 2011 Third Quarter Financial Results 4Cardica Announces Fiscal 2011 Third Quarter Financial Results 5Cardica Announces Fiscal 2011 Third Quarter Financial Results 6Cobalis Corp. Launches National Television Commercials for PreHistin® Allergy Defense Formula 2Cobalis Corp. Launches National Television Commercials for PreHistin® Allergy Defense Formula 3
The MicroMed DeBakey VAD is a miniaturized heart pump designed to provide increased blood flow (up to 10L/min) from the left ventricle of the heart throughout the body for patients in end stage heart...
... VH Fibrin Sealant has been shown to ... repair. Containing uniform, reproducible concentrations of fibrinogen ... the final stage of the coagulation cascade ... that firmly adheres to connective tissue like ...
... catheter provides maximum heat exchange power ... The Fortius catheter incorporates a proprietary ... the ultimate solution for endovascular cooling ... percutaneously into the femoral vein residing ...
...
Medicine Products: